CD30+ Stage IV Hodgkin Lymphoma - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Supreme Court says children have fundamental right to internet access, rejects blanket bans

Editorial infographic showing affordable fragrance mists becoming a growth area for beauty companies, with product imagery and panels highlighting stronger US mass-market fragrance growth, new launches from major beauty groups, and the key business question of whether lower-priced scents can drive repeat purchases.

Why L’Oréal, Coty and Unilever are betting on affordable fragrance mists

Pope Leo XIV returns to public duties after lung cancer surgery

Deadly fire at Canadian military base in Alberta prompts major investigation

Read More

Pharma Industry News

EC approves ADCETRIS for treating CD30+ Stage IV Hodgkin lymphoma

The European Commission (EC) has officially expanded the approval of Takeda Pharmaceutical’s ADCETRIS (brentuximab vedotin) to include the…

bypharmanewsdaily

February 11, 2019

web analytics